<DOC>
	<DOCNO>NCT00408330</DOCNO>
	<brief_summary>This study determine whether medication market indication effective safe treat seborrheic dermatitis face .</brief_summary>
	<brief_title>A Study Azelaic Acid ( AzA ) 15 % Gel Treatment Seborrheic Dermatitis Face</brief_title>
	<detailed_description>To test efficacy safety azelaic acid 15 % gel treatment seborrheic dermatitis face</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Seborrheic</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Stable exacerbate seborrheic dermatitis facial area Psoriasis Atopic dermatitis Facial acne rosacea Dermatophytic skin infection Parkinson 's disease Known immunosuppression ; HIV infection Any condition require continuous systemic topical corticosteroid antimycotic therapy Continuous asthma inhalation treatment require &gt; 800 mg corticosteroid Any severe disease likely interfere conduct plan termination study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>